Yearly Archives: 2022

Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely anticipated Celeste® specialized phototherapy device, PhotoPharmics, today announced plans to begin recruitment for the Celeste Light for PD trial in December. “Multiple forces have aligned to make the timing for […]

Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent’s goal of changing the course of reproductive health. Inherent seeks to redefine the […]

Last week, BioHive kicked off its celebration of “STEM September” with an evening of networking in downtown Salt Lake City. Life sciences professionals joined from all over the Salt Lake Valley to connect with the industry and support the efforts of BioHive. “I was so inspired hearing stories from the people that make Utah’s life […]

New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications Fluidx Medical announces completion of trial enrollment for its novel embolic device, GPX. In this multi-center trial, GPX was used to treat a variety of primary and metastatic tumors, renal adenoma tumors, and a range […]

U.S. Senator Mike Lee (R-UT) on August 15 spent the day connecting with Utah’s life sciences community, known as the BioHive, touring facilities at BD, IONIQ Sciences, SEEK Labs and Carterra. His schedule also included a tour of Altitude Lab in the University of Utah’s Research Park where he led a roundtable discussion with nearly […]